Related references
Note: Only part of the references are listed.The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
Wei-Chung Chiou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
James T. England et al.
BLOOD REVIEWS (2021)
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - anin silicodocking and molecular dynamics simulation study
Rajesh Ghosh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
Sk. Abdul Amin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Effects of epigallocatechin-3-gallate and acyclovir on herpes simplex virus type 1 infection in oral epithelial cells
Ching-Yi Wu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Immune determinants of COVID-19 disease presentation and severity
Petter Brodin
NATURE MEDICINE (2021)
Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned
Varvara A. Ryabkova et al.
CLINICAL IMMUNOLOGY (2021)
Inactivation of SARS-CoV-2 by Catechins from Green Tea
Hidekazu Nishimura et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2021)
EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
Mukesh Chourasia et al.
MOLECULES (2021)
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
Ashuai Du et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
The first 12 months of COVID-19: a timeline of immunological insights
Thiago Carvalho et al.
NATURE REVIEWS IMMUNOLOGY (2021)
ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication
Zi-yu Wang et al.
ACTA PHARMACOLOGICA SINICA (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
The Impact of Coconut Oil and Epigallocatechin Gallate on the Levels of IL-6, Anxiety and Disability in Multiple Sclerosis Patients
Jose Luis Platero et al.
NUTRIENTS (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Advanced Nanovehicles-Enabled Delivery Systems of Epigallocatechin Gallate for Cancer Therapy
Kai Li et al.
FRONTIERS IN CHEMISTRY (2020)
Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study
Jing Gong et al.
BMC INFECTIOUS DISEASES (2020)
Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
Giovanna Giovinazzo et al.
MOLECULES (2020)
Nano- and micro-particles for delivery of catechins: Physical and biological performance
Jian-Hui Ye et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model
Nithya Ramesh et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Interactions of tea catechins with intestinal microbiota and their implication for human health
Tongtong Guo et al.
FOOD SCIENCE AND BIOTECHNOLOGY (2019)
Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study
Gamal Shiha et al.
SCIENTIFIC REPORTS (2019)
Emerging and Reemerging Infectious Diseases: Global Overview Preface
Alimuddin Zumla et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
The role of the microbiota in infectious diseases
Josie Libertucci et al.
NATURE MICROBIOLOGY (2019)
Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced acute lung injury by suppression of TLR4/NF-κB signaling activation
Jia Wang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2019)
Epigallocatechin-3-gallate suppresses neutrophil migration speed in a transgenic zebrafish model accompanied by reduced inflammatory mediators
Thao Nguyen et al.
JOURNAL OF INFLAMMATION RESEARCH (2019)
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Lucy C. K. Bell et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis
Sabine Ehrt et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Ecology and evolution of Mycobacterium tuberculosis
Sebastien Gagneux
NATURE REVIEWS MICROBIOLOGY (2018)
The safety of green tea and green tea extract consumption in adults - Results of a systematic review
Jiang Hu et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Bioavailability of Tea Catechins and Its Improvement
Zhuo-Yu Cai et al.
MOLECULES (2018)
Global Epidemiology of Tuberculosis
Philippe Glaziou et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice
Yu-Heng Lai et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein
Nitin Sharma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Food macromolecule based nanodelivery systems for enhancing the bioavailability of polyphenols
Bing Hu et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2017)
The role of oxidative stress in influenza virus infection
Miaomiao Liu et al.
MICROBES AND INFECTION (2017)
Tea Drinking and Its Association with Active Tuberculosis Incidence among Middle-Aged and Elderly Adults: The Singapore Chinese Health Study
Avril Zixin Soh et al.
NUTRIENTS (2017)
Oxidative stress-induced diseases and tea polyphenols
Xiangbing Mao et al.
ONCOTARGET (2017)
EGCG Maintains Th1/Th2 Balance and Mitigates Ulcerative Colitis Induced by Dextran Sulfate Sodium through TLR4/MyD88/NF-κB Signaling Pathway in Rats
Xue Bing et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Nikolay N. Kuzmich et al.
VACCINES (2017)
Epigallocatechin-3-gallate Prevents Triptolide-Induced Hepatic Injury by Restoring the Th17/Treg Balance in Mice
Shu-Jing Yu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2016)
Impact of molecular weight on the formation of electrosprayed chitosan microcapsules as delivery vehicles for bioactive compounds
Laura G. Gomez-Mascaraque et al.
CARBOHYDRATE POLYMERS (2016)
Virus and Host Testing to Manage Chronic Hepatitis B
Grace Lai-Hung Wong et al.
CLINICAL INFECTIOUS DISEASES (2016)
Therapeutic effects of EGCG: a patent review
Leewanshi Chakrawarti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
Ameeruddin Nusrath Unissa et al.
INFECTION GENETICS AND EVOLUTION (2016)
Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis
Dayong Wu
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
Annelies Stevaert et al.
MEDICINAL RESEARCH REVIEWS (2016)
Impact of tea drinking upon tuberculosis: a neglected issue
Mengshi Chen et al.
BMC PUBLIC HEALTH (2015)
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
Juan Tamargo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Linear and branched alkyl-esters and amides of gallic acid and other (mono-, di- and tri-) hydroxy benzoyl derivatives as promising anti-HCV inhibitors
Eva Rivero-Buceta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Influenza virus-induced lung injury: pathogenesis and implications for treatment
Susanne Herold et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
Michael Nassal
GUT (2015)
Catechin inhibition of influenza neuraminidase and its molecular basis with mass spectrometry
Patrick Mueller et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action
Noemie Calland et al.
JOURNAL OF VIROLOGY (2015)
Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication
L. Zhong et al.
CELL DEATH & DISEASE (2015)
Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice
Zhenglei Xu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets
Jae-Kyeong Byun et al.
IMMUNOLOGY LETTERS (2014)
Epigallocatechin-3-gallate sensitizes IFN-γ-stimulated CD4+ T cells to apoptosis via alternative activation of STAT1
Xingxin Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Simultaneous detection of green tea catechins and gallic acid in human serum after ingestion of green tea tablets using ion-pair high-performance liquid chromatography with electrochemical detection
Keiko Narumi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals
Shu Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B
J. Li et al.
JOURNAL OF VIRAL HEPATITIS (2014)
EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1α with Th17/Treg Control
Eun-Ji Yang et al.
PLOS ONE (2014)
Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate
Meehyein Kim et al.
ANTIVIRAL RESEARCH (2013)
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea
J. Steinmann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
Tait D. Shanafelt et al.
CANCER (2013)
Role of oxidative stress in infectious diseases. A review
Miroslav Pohanka
FOLIA MICROBIOLOGICA (2013)
Bioactive Peptides/Chitosan Nanoparticles Enhance Cellular Antioxidant Activity of (-)-Epigallocatechin-3-gallate
Bing Hu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications
Munkyong Pae et al.
FOOD & FUNCTION (2013)
CD4(+)T Cells: Differentiation and Functions
Rishi Vishal Luckheeram et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
Noemie Calland et al.
HEPATOLOGY (2012)
Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients
Pawel Bogdanski et al.
NUTRITION RESEARCH (2012)
Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection
En-Qiang Chen et al.
VIROLOGY JOURNAL (2012)
Effects of Green Tea Catechins and Theanine on Preventing Influenza Infection among Healthcare Workers: A Randomized Controlled Trial
Keiji Matsumoto et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
The Green Tea Polyphenol, Epigallocatechin-3-Gallate, Inhibits Hepatitis C Virus Entry
Sandra Ciesek et al.
HEPATOLOGY (2011)
Catechin inhibits adhesion and migration of peripheral blood B cells by blocking CD11b
Kazushige Kawai et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2011)
Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
Derliz Mereles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line
Wei He et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium?
Smitha J. Sasindran et al.
FRONTIERS IN MICROBIOLOGY (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Molecular genetics of HBV infection
Stephen Locarnini et al.
ANTIVIRAL THERAPY (2010)
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
Neel R. Gandhi et al.
LANCET (2010)
Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen
Astha Agarwal et al.
PHYTOMEDICINE (2010)
Innate immunity and inflammation - two facets of the same anti-infectious reaction
M. Si-Tahar et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling
Dayong Wu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Tea polyphenols exerts anti-hepatitis B virus effects in a stably HBV-transfected cell line
Pian Ye et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2009)
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus
Charles E. Isaacs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Are polyphenols antioxidants or pro-oxidants?: What do we learn from cell culture and in vivo studies?
Barry Halliwell
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis
Shailendra Kumar Sharma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives:: Effect of alkyl chain length
Shuichi Mori et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Safety of green tea extracts - A systematic review by the US Pharmacopeia
Dandapantula N. Sarma et al.
DRUG SAFETY (2008)
An ecological and evolutionary perspective on human-microbe mutualism and disease
Les Dethlefsen et al.
NATURE (2007)
Transforming growth factor-β suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA
Yu-Chi Chou et al.
HEPATOLOGY (2007)
(-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury
Y. Wang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins
G Galati et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages
PK Anand et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Comparison of the antioxidant activity of roasted tea with green, oolong, and black teas
E Satoh et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2005)
Antiviral effect of catechins in green tea on influenza virus
JM Song et al.
ANTIVIRAL RESEARCH (2005)
Epigallocatechin gallate attenuates adhesion and migration of CD8+ T cells by binding to CD11b
K Kawai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
A single ascending dose study of epigallocatechin gallate in healthy volunteers
U Ullmann et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2003)
Minimum molecular architectures for transcription and replication of the influenza virus
A Honda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes
C Wilasrusmee et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2002)
Protective effect of green tea extract against the erythrocytic oxidative stress injury during Mycobacterium tuberculosis infection in mice
RS Guleria et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent
G Fassina et al.
AIDS (2002)
Hijacking the host: survival of pathogenic mycobacteria inside macrophages
J Pieters et al.
TRENDS IN MICROBIOLOGY (2002)
Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells
N Imanishi et al.
MICROBIOLOGY AND IMMUNOLOGY (2002)
Share Paper
